000			02052 a2200613 4500
005			20250515135425.0
264		0	_c20090408
008			200904s 0 0 eng d
022			_a1476-5551
024	7		_a10.1038/leu.2008.248 _2doi
040			_aNLM _beng _cNLM
100	1		_aWillems, E
245	0	0	_aNon-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. _h[electronic resource]
260			_bLeukemia _cMar 2009
300			_a608-10 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aCD8-Positive T-Lymphocytes _ximmunology
650	0	4	_aCarcinoma, Renal Cell _xsecondary
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHematologic Neoplasms _xsurgery
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aKidney Neoplasms _xpathology
650	0	4	_aLymphocyte Depletion
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyelodysplastic Syndromes _xsurgery
650	0	4	_aMyeloproliferative Disorders _xsurgery
650	0	4	_aPeripheral Blood Stem Cell Transplantation _xmethods
650	0	4	_aTransplantation Conditioning _xmethods
650	0	4	_aTransplantation, Homologous
650	0	4	_aVidarabine _xanalogs & derivatives
650	0	4	_aWhole-Body Irradiation
700	1		_aBaron, F
700	1		_aBaudoux, E
700	1		_aWanten, N
700	1		_aSeidel, L
700	1		_aVanbellinghen, J-F
700	1		_aHerens, C
700	1		_aGothot, A
700	1		_aFrère, P
700	1		_aBonnet, C
700	1		_aHafraoui, K
700	1		_aVanstraelen, G
700	1		_aFillet, G
700	1		_aBeguin, Y
773	0		_tLeukemia _gvol. 23 _gno. 3 _gp. 608-10
856	4	0	_uhttps://doi.org/10.1038/leu.2008.248 _zAvailable from publisher's website
999			_c18268089 _d18268089